Jaguar Health, Inc. (NASDAQ:JAGX)

COMMUNIQUÉ DE PRESSE

publié le 16/03/2026 à 14:00, il y a 2 mois 4 jours

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Magdalena Biosciences initiates preclinical study on whole leaf coca extract for appetite suppression post-GLP-1 weight loss. Study conducted in Alberta, Canada

Weight Loss Magdalena Biosciences Preclinical Study Appetite Suppression Whole Leaf Coca Extract
BRÈVE

publiée le 11/03/2026 à 14:05, il y a 2 mois 9 jours

Jaguar Health to Present at Life Sciences Investor Forum

Crofelemer Virtual Presentation Jaguar Health Gastrointestinal Disorders Life Sciences Forum
BRÈVE

publiée le 11/03/2026 à 14:05, il y a 2 mois 9 jours

Jaguar Health présentera ses services au Forum des investisseurs en sciences de la vie

Crofelemer Jaguar Health Présentation Virtuelle Troubles Gastro-intestinaux Forum Des Sciences De La Vie
COMMUNIQUÉ DE PRESSE

publié le 11/03/2026 à 14:00, il y a 2 mois 9 jours

Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
Jaguar Health, Inc. to present virtually at Life Sciences Investor Forum on March 12, 2026. More about Jaguar's novel prescription drugs for gastrointestinal diseases

Gastrointestinal Diseases Virtual Presentation Jaguar Health Prescription Drugs Life Sciences Investor Forum
BRÈVE

publiée le 09/03/2026 à 14:05, il y a 2 mois 11 jours

Jaguar Health améliore sa situation financière grâce à une restructuration de sa dette

Santé Financière Restructuration De La Dette Développement Crofelemer Insuffisance Intestinale Obligations De Redevances
BRÈVE

publiée le 09/03/2026 à 14:05, il y a 2 mois 11 jours

Jaguar Health Enhances Financial Position Through Debt Restructuring

Financial Health Debt Restructuring Crofelemer Development Intestinal Failure Royalty Obligations
COMMUNIQUÉ DE PRESSE

publié le 09/03/2026 à 14:00, il y a 2 mois 11 jours

Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants
Jaguar Health, Inc. strengthens balance sheet by restructuring debt and royalty obligations. Sharp focus on global development program for crofelemer. CEO Lisa Conte prioritizes capitalization

Jaguar Health Inc. Debt Reduction Balance Sheet Restructuring Crofelemer Global Development Lisa Conte CEO
BRÈVE

publiée le 03/03/2026 à 15:05, il y a 2 mois 17 jours

Jaguar Health reçoit un paiement supplémentaire de 3 millions de dollars de Future Pak

Crofelemer Jaguar Health Mytesi Insuffisance Intestinale Future Pak
BRÈVE

publiée le 03/03/2026 à 15:05, il y a 2 mois 17 jours

Jaguar Health Receives Additional $3 Million Payment from Future Pak

Crofelemer Jaguar Health Mytesi Intestinal Failure Future Pak
COMMUNIQUÉ DE PRESSE

publié le 03/03/2026 à 15:00, il y a 2 mois 17 jours

Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
Jaguar Health, Inc. receives $16M non-dilutive capital from U.S. license agreement with Future Pak for crofelemer drugs. Strategy focuses on rare-disease intestinal failure indications

Non-dilutive Capital Jaguar Health Intestinal Failure Future Pak Crofelemer Drugs

Publié le 20/05/2026 à 18:00, il y a 9 heures 57 minutes

General shareholders meeting of 20 May, 2026
Publié le 20/05/2026 à 18:00, il y a 9 heures 57 minutes

General shareholders meeting of 20 May, 2026
Publié le 20/05/2026 à 18:00, il y a 9 heures 57 minutes

Algemene vergadering van 20 mei 2026
Publié le 20/05/2026 à 17:45, il y a 10 heures 12 minutes

STEF : Droits de vote au 30-04-2026
Publié le 20/05/2026 à 17:45, il y a 10 heures 12 minutes

Report on share repurchases from 13 to 19 May 2026

Voir tout LES ECHOS COMFI WIRE

Publié le 21/05/2026 à 01:25, il y a 2 heures 32 minutes

Mongolia Growth Group Announces Completion of Arrangement and Changes to the Board and Executive Leadership
Publié le 20/05/2026 à 22:40, il y a 5 heures 17 minutes

Jaguar Health Reports First Quarter 2026 Financials
Publié le 20/05/2026 à 22:15, il y a 5 heures 42 minutes

Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Publié le 20/05/2026 à 15:28, il y a 12 heures 29 minutes

Sarama Resources Announces Private Equity Placement of A$1.5m
Publié le 20/05/2026 à 15:01, il y a 12 heures 56 minutes

Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer

Voir tout ACCESSWIRE

Publié le 20/05/2026 à 22:00, il y a 5 heures 57 minutes

Nebius and Bloom Energy partner to power AI infrastructure build-out
Publié le 20/05/2026 à 21:35, il y a 6 heures 21 minutes

IGEL and Zscaler Release Healthcare Security Blueprints for Distributed Care Delivery
Publié le 20/05/2026 à 20:15, il y a 7 heures 41 minutes

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S expands capacity for AI substrates
Publié le 20/05/2026 à 19:34, il y a 8 heures 22 minutes

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Final Results Announcement
Publié le 20/05/2026 à 19:34, il y a 8 heures 23 minutes

EQS-Adhoc: AT&S Austria Technologie & Systemtechnik AG: AT&S intends to issue a (Hybrid) Convertible Bond and/or a Hybrid Bond; no dividend for the financial year 2025/26

Voir tout EQS

News